These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8341216)

  • 1. Chemotherapy in the management of infantile fibrosarcoma.
    Kynaston JA; Malcolm AJ; Craft AW; Davies SM; Jones PH; King DJ; Mitchell CD; Oakhill A; Stiller CA
    Med Pediatr Oncol; 1993; 21(7):488-93. PubMed ID: 8341216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemotherapy in the treatment of infantile fibrosarcoma.
    Shetty AK; Yu LC; Gardner RV; Warrier RP
    Med Pediatr Oncol; 1999 Oct; 33(4):425-7. PubMed ID: 10491560
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital-infantile fibrosarcoma of the foot--avoidance of amputation.
    Nason GJ; Baker JF; Seoighe D; Irvine AD; McDermott M; Orr D; Capra M; Kelly PM
    Ir Med J; 2014 May; 107(5):148-9. PubMed ID: 24908860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.
    Russell H; Hicks MJ; Bertuch AA; Chintagumpala M
    Pediatr Blood Cancer; 2009 Jul; 53(1):23-7. PubMed ID: 19340853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience.
    Orbach D; Brennan B; De Paoli A; Gallego S; Mudry P; Francotte N; van Noesel M; Kelsey A; Alaggio R; Ranchère D; De Salvo GL; Casanova M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Ferrari A
    Eur J Cancer; 2016 Apr; 57():1-9. PubMed ID: 26849118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital fibrosarcoma. Preoperative chemotherapy and conservative surgery.
    Ninane J; Gosseye S; Panteon E; Claus D; Rombouts JJ; Cornu G
    Cancer; 1986 Oct; 58(7):1400-6. PubMed ID: 3755646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic angiosarcoma in a child: successful therapy with surgery and adjuvant chemotherapy.
    Gunawardena SW; Trautwein LM; Finegold MJ; Ogden AK
    Med Pediatr Oncol; 1997 Feb; 28(2):139-43. PubMed ID: 8986151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infantile fibrosarcoma: retrospective analysis of eleven patients.
    Akyüz C; Küpeli S; Varan A; Gedikoglu G; Yalçin B; Kutluk T; Büyükpamukçu M
    Tumori; 2011; 97(2):166-9. PubMed ID: 21617710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatoblastoma: response to chemotherapy.
    Vannier JP; Flamant F; Hemet J; Caillaud JM; Gruner M; Bachy B; Lefur R; Lemerle J; Tron P
    Med Pediatr Oncol; 1991; 19(3):187-91. PubMed ID: 1708850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
    Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for inoperable infantile fibrosarcoma.
    Grier HE; Perez-Atayde AR; Weinstein HJ
    Cancer; 1985 Oct; 56(7):1507-10. PubMed ID: 4027886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas.
    Crist WM; Raney RB; Ragab A; Heyn R; Wharam M; Webber B; Johnston J; Beltangady M
    Med Pediatr Oncol; 1987; 15(2):51-7. PubMed ID: 3587117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile fibrosarcoma. Report of a case with long-term follow-up.
    Robinson W; Crawford AH
    J Bone Joint Surg Am; 1990 Feb; 72(2):291-4. PubMed ID: 2303517
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal ganglioneuroblastoma--complete response to chemotherapy alone.
    Raina V; Kamble R; Tanwar R; Singh SP; Sharma S
    Postgrad Med J; 1993 Sep; 69(815):746-8. PubMed ID: 8255850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newborn with infantile fibrosarcoma of foot: treatment with chemotherapy and extremity-sparing surgery.
    Akyüz C; Sari N; Vargel I; Gedikoglu G; Haliloglu M; Büyükpamukçu M
    J Perinatol; 2010 Jan; 30(1):63-5. PubMed ID: 20038940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.